- 全部删除
- 您的购物车当前为空
Compound A8 (DualCathepsinL/JAK-IN-1) 是一种Cathepsin L(CTSL) 和JAK的双重抑制剂,其对CTSL、JAK1/2/3和TYK2的IC50分别为0.68 μM、337.1 nM、5.251 nM、27.29 nM 和172.6 nM。该化合物有效阻断MAPK、NF-κB和JAK/STAT信号通路的激活,具有显著的抗炎效果,可用于急性肺损伤 (ALI) 的研究。
Compound A8 (DualCathepsinL/JAK-IN-1) 是一种Cathepsin L(CTSL) 和JAK的双重抑制剂,其对CTSL、JAK1/2/3和TYK2的IC50分别为0.68 μM、337.1 nM、5.251 nM、27.29 nM 和172.6 nM。该化合物有效阻断MAPK、NF-κB和JAK/STAT信号通路的激活,具有显著的抗炎效果,可用于急性肺损伤 (ALI) 的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | DualCathepsinL/JAK-IN-1 (Compound A8) serves as a dual inhibitor of Cathepsin L (CTSL) and JAK, exhibiting IC50 values of 0.68 μM for CTSL and 337.1 nM, 5.251 nM, 27.29 nM, and 172.6 nM for JAK1/2/3 and TYK2, respectively. This compound effectively prevents the activation of MAPK, NF-κB, and JAK/STAT signaling pathways, leading to significant anti-inflammatory therapeutic effects. DualCathepsinL/JAK-IN-1 is applicable in research on acute lung injury (ALI). |
靶点活性 | Tyk2:172.6 nM |
分子量 | 351.833 |
分子式 | C19H18ClN5 |
CAS No. | 2450279-41-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容